Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- 84 Evaluation of suspected immunodeficiency
- 85 Infections in the neutropenic patient
- 86 Infections in patients with neoplastic disease
- 87 Corticosteroids, cytotoxic agents, and infection
- 88 Biologics
- 89 Infections in transplant recipients
- 90 Diabetes and infection
- 91 Infectious complications in the injection and non-injection drug user
- 92 Infections in the alcoholic
- 93 Infections in the elderly
- 94 Neonatal infection
- 95 Pregnancy and the puerperium: infectious risks
- 96 Dialysis-related infection
- 97 Overwhelming postsplenectomy infection
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
97 - Overwhelming postsplenectomy infection
from Part XI - The susceptible host
Published online by Cambridge University Press: 05 April 2015
Edited by
Book contents
- Frontmatter
- Dedication
- Contents
- List of Contributors
- Preface
- Part I Clinical syndromes: general
- Part II Clinical syndromes: head and neck
- Part III Clinical syndromes: eye
- Part IV Clinical syndromes: skin and lymph nodes
- Part V Clinical syndromes: respiratory tract
- Part VI Clinical syndromes: heart and blood vessels
- Part VII Clinical syndromes: gastrointestinal tract, liver, and abdomen
- Part VIII Clinical syndromes: genitourinary tract
- Part IX Clinical syndromes: musculoskeletal system
- Part X Clinical syndromes: neurologic system
- Part XI The susceptible host
- 84 Evaluation of suspected immunodeficiency
- 85 Infections in the neutropenic patient
- 86 Infections in patients with neoplastic disease
- 87 Corticosteroids, cytotoxic agents, and infection
- 88 Biologics
- 89 Infections in transplant recipients
- 90 Diabetes and infection
- 91 Infectious complications in the injection and non-injection drug user
- 92 Infections in the alcoholic
- 93 Infections in the elderly
- 94 Neonatal infection
- 95 Pregnancy and the puerperium: infectious risks
- 96 Dialysis-related infection
- 97 Overwhelming postsplenectomy infection
- Part XII HIV
- Part XIII Nosocomial infection
- Part XIV Infections related to surgery and trauma
- Part XV Prevention of infection
- Part XVI Travel and recreation
- Part XVII Bioterrorism
- Part XVIII Specific organisms: bacteria
- Part XIX Specific organisms: spirochetes
- Part XX Specific organisms: Mycoplasma and Chlamydia
- Part XXI Specific organisms: Rickettsia, Ehrlichia, and Anaplasma
- Part XXII Specific organisms: fungi
- Part XXIII Specific organisms: viruses
- Part XXIV Specific organisms: parasites
- Part XXV Antimicrobial therapy: general considerations
- Index
- References
Summary
A summary is not available for this content so a preview has been provided. Please use the Get access link above for information on how to access this content.
- Type
- Chapter
- Information
- Clinical Infectious Disease , pp. 629 - 636Publisher: Cambridge University PressPrint publication year: 2015
References
. Advisory Committee on Immunization Practices (ACIP) immunization schedules for persons aged through 18 years and adults 19 years and older – United States, 2013. MMWR Morb Mortal Weekly Rep. 2013;62(Suppl 1):1–21.Google Scholar
, . Acute infectious purpura fulminans: a 15-year review of 28 consecutive cases. Am Surg. 2003;69:86–90.Google ScholarPubMed
, , , et al. Prophylaxis with oral penicillin in children with sickle cell anemia: a randomized trial. N Engl J Med. 1986;314:1593–1599.CrossRefGoogle ScholarPubMed
, , . Post-splenectomy sepsis and its mortality rate: actual versus perceived risks. Br J Surg. 1991;78:1031–1038.CrossRefGoogle Scholar
, , , et al. The morbidity and mortality of pediatric splenectomy: does prophylaxis make a difference? J Pediatr Surg. 1999;34:1064–1067.CrossRefGoogle Scholar
, , , et al. Normal IgG and impaired IgM responses to polysaccharide vaccines in asplenic patients. J Infect Dis. 1999;179:513–517.CrossRefGoogle ScholarPubMed
. Infection associated with asplenia: risks, mechanisms, and prevention. Am J Med. 1990;88(5N):33N–42N.Google Scholar
, , , et al. Combined schedule of 7-valent pneumococcal conjugate vaccine followed by 23-valent pneumococcal vaccine in children and young adults with sickle cell anemia. J Pediatr. 1998;133:275–278.CrossRefGoogle Scholar
, , , et al. Decline in invasive pneumococcal disease after the introduction of protein-polysaccharide conjugate vaccine. N Engl J Med. 2003;348:1737–1746.CrossRefGoogle ScholarPubMed
. Guidelines for the Treatment of Malaria. Geneva, Switzerland: World Health Organization; 2006.Google Scholar